Navigation Links
Navigating Cancer Announces Milestones Related to Patient Education Program
Date:1/7/2014

SEATTLE, Jan. 7, 2014 /PRNewswire/ -- Navigating Cancer, the leading provider of oncology specific patient portals, announces milestones related to their Patient Education and Medication Adherence Program launched in early 2013. Navigating Cancer's Patient Education Program allows cancer programs to digitize their education and establish intuitive rules to automatically deliver information to individual patients based on their diagnosis and medications, without requiring additional work from staff members.  Additionally, the program allows material to be delivered at specific points during the patient's treatment journey — after diagnosis to aid understanding, or during treatment milestones to help patients learn how to take their medications and manage side effects to improve adherence and compliance.  In 2014, HITECH Meaningful Use Stage 2 requires practices to use certified EHR technology to provide personalized patient education, a change from Stage 1 where the patient education measure was optional. Navigating Cancer also supports the Infobutton standard for patient education as required for Stage 2.

Navigating Cancer's Patient Education Program achieved the following in 2013:

  • 97% of providers met HITECH Meaningful Use Stage 1 requirement for patient education
  • 97% of patients at participating practices signed a HIPAA authorization to opt in to the program, indicating a high preference for receiving personalized education from their providers
  • Nearly 300 different educational programs were implemented to educate specific cancer patients with content from the National Cancer Institute, pharmaceutical manufacturers and other cancer specific partners. 74% of registered patients received education specific to their diagnosis and/or medications.

"Our goals for everything we do are two-fold: to empower cancer patients and
'/>"/>

SOURCE Navigating Cancer
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Thomson Reuters Reveals New Strategies for Navigating Big Data in the Pharmaceutical Industry
2. New Mobile App Assists Oncologists In Navigating Ever-Evolving Sea Of Cancer Information
3. Tennessee Oncology Chooses Navigating Cancers Patient Engagement Portal
4. Health Outcomes Liaisons Key to Pharmaceutical Sector Navigating Payer-Focused Marketplace
5. Second Webinar in MedTech Trends Webcast Series on November 28, 2012; Navigating & Understanding the Sealing and Handling of Medical Microporous Materials
6. Sutro Biopharma to Collaborate With Memorial Sloan-Kettering Cancer Center to Produce Bispecific Antibodies for the Treatment of Neuroblastoma
7. Specialised Therapeutics Australia Partners with Genomic Health Inc. to Deliver Novel Genomic Test to Breast Cancer Patients
8. Clinical Trial Participation Today May Lead To Future Breakthroughs In Pancreatic Cancer, One Of The Nations Deadliest Cancers
9. According to Surveyed U.S. Oncologists, Perjeta is Prescribed to Over One-Third of First-Line Advanced/Metastatic HER2-Positive, HR-Negative Breast Cancer Patients
10. Elekta announces strategic partnership with McLaren Health Care to improve cancer care in Michigan
11. New Addition to the Prostate Cancer Roundtable Policy Agenda Addresses Quality-of-Life Endpoints
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... NEW YORK , Oct. 31, 2014  Grammy ... performance to a high-profile audience of philanthropists, athletes, actors, ... Foundation Gala on Wednesday, November 19 at the Mandarin ... . This year,s fundraising event will honor six individuals ... The Orthopaedic Foundation will bestow its highest honor, ...
(Date:10/31/2014)... , Oct. 31, 2014  Australian biopharmaceutical company Specialised ... (nanoparticle albumin-bound paclitaxel) in combination with gemcitabine, will ... patients with metastatic pancreatic cancer from 1 November. ... cancer is the 5 th most common cause ... all cancer deaths, with the lowest 5-year survival of ...
(Date:10/31/2014)... ARBOR, Mich. , Oct. 31, 2014 /PRNewswire/ ... immune modulators to treat autoimmune disease and cancer, ... of novel synthetic RORgamma agonist product candidates will ... Society for Immunotherapy of Cancer (SITC) being held ... & Convention Center, National Harbor, MD.  The poster, ...
Breaking Medicine Technology:10th Anniversary Orthopaedic Foundation Gala Set For Success 2Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 2Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 3Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 4Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 5Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 6Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 7Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 8Lycera Announces Presentation of Data on Anti-Tumor Activity of Novel Synthetic RORgamma Agonists at Society for Immunotherapy of Cancer Meeting 2
... 2011 Nektar Therapeutics (Nasdaq: NKTR ) today reported ... Cash, cash equivalents, and investments at September 30, ... 31, 2010. Revenue for the third quarter of ... in the third quarter of 2010 primarily as a result of ...
... NEW YORK, Nov. 2, 2011 JDRF and The Leona ... largest non-government funders of type 1 diabetes (T1D) programs, announced ... a new level of cooperation between the organizations. The goal ... and development to deliver better treatments, devices, and diagnostics for ...
Cached Medicine Technology:Nektar Therapeutics Reports Third Quarter 2011 Financial Results 2Nektar Therapeutics Reports Third Quarter 2011 Financial Results 3Nektar Therapeutics Reports Third Quarter 2011 Financial Results 4Nektar Therapeutics Reports Third Quarter 2011 Financial Results 5Nektar Therapeutics Reports Third Quarter 2011 Financial Results 6Nektar Therapeutics Reports Third Quarter 2011 Financial Results 7Nektar Therapeutics Reports Third Quarter 2011 Financial Results 8JDRF and the Helmsley Charitable Trust Form a Collaboration to Accelerate Innovative Type 1 Diabetes Research and Development 2JDRF and the Helmsley Charitable Trust Form a Collaboration to Accelerate Innovative Type 1 Diabetes Research and Development 3JDRF and the Helmsley Charitable Trust Form a Collaboration to Accelerate Innovative Type 1 Diabetes Research and Development 4
(Date:10/31/2014)... In the first study of its kind, Rice University ... circuits that cause cancer cells to become metastatic. The ... allows cancer cells to both migrate and form new ... to new drugs that interfere with the genetic switches ... cells and circulating tumor cells -- two of the ...
(Date:10/31/2014)... Daily Gossip writes in its Xtreme Fat Loss review that ... loss program ever developed. It promises to provide users the ... no wonder after all that this has become the most ... and workout fat loss program was created by Joel Marion, ... the author of this fat loss system, the method can ...
(Date:10/31/2014)... With all the preparations families carry out ... may overlook one critical area – the potential for ... performance and even behavior. Typical children’s vision screenings at ... vision problems, and to address this challenge, Dr. Rosenak’s ... The Awesome Eyes Student Vision Program. , The ...
(Date:10/31/2014)... FRIDAY, Oct. 31, 2014 (HealthDay News) -- Sleep apnea may ... as where you parked your car or left your house ... with severe sleep apnea showed that this ability -- called ... eye movement (REM) sleep, even when other stages of sleep ... during which dreams typically occur. "We,ve shown for the ...
(Date:10/31/2014)... say that either they or a family member have ... latest issue of The Gerontological Society of America,s ... which goes on to show that Americans strongly support ... end-of-life health care wishes. , This PP&AR , ... features 12 articles that present new ways of understanding ...
Breaking Medicine News(10 mins):Health News:Decoding the emergence of metastatic cancer stem cells 2Health News:Decoding the emergence of metastatic cancer stem cells 3Health News:Xtreme Fat Loss Diet Review Reveals How to Transform Your Body in 25 Days 2Health News:New School Vision Initiative Announced by Dr. Rosenak’s Optical Options; Program Aims to Help Recognize Unseen Vision Problems That Impact School Success 2Health News:New School Vision Initiative Announced by Dr. Rosenak’s Optical Options; Program Aims to Help Recognize Unseen Vision Problems That Impact School Success 3Health News:Sleep Apnea May Steal Some of Your Memory: Study 2Health News:Advance directives can benefit patients, families, and health care system 2
... the leading cause of disability among adults. As the population ... // and public health toll of this chronic, crippling joint ... early diagnosis, moderate exercise is one of the most effective ... OA of the knee and hip. , ...
... high fat and sugar induces abnormalities in immune systems, which ... liver, according to a study of mice // conducted by ... published in the Oct. issue of the journal Hepatology, found ... more weight, but also developed fatty livers and increased levels ...
... cause of mortality in patients with muscular dystrophy and ... and approximately 70 % of those with Becker muscular ... muscular dystrophy caused by defects in a gene called ... heart failure and premature death. , ,Cardiac symptoms ...
... Stony Brook University's School of Dental Medicine have developed ... and confections and will not promote cavity formation in ... technology, which has been named CaviStat(R), is more effective ... tooth decay. This conclusion was arrived at after testing ...
... of bilateral muscle weakness with areflexia provoked by ... Cataplexy is diagnosed based on clinical interview. Two ... their usefulness has been limited because of length ... ,Used effectively even these screening tests require the ...
... studies that suggested that radiation treatment for prostate cancer ... suppress hormones. // , ,Researchers at Johns Hopkins ... that hormone therapy will not diminish the value of ... and remains undiagnosed and can present late when the ...
Cached Medicine News:Health News:Exercise Can Strenghten Knee Cartilage 2Health News:Hormone Treatment Before Radiation for Prostate Cancer 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: